Related Experiment Video
Updated: Sep 20, 2025

Multimodality Diagnosis of Mesenteric Ischemia
Published on: July 21, 2023
COVID-19 and Intestinal Ischemia: A Multicenter Case Series
Maryam Sarkardeh1,2, Elahe Meftah3, Narjes Mohammadzadeh4
1Surgical Oncology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
COVID-19 can lead to severe gastrointestinal issues like bowel necrosis, with a high mortality rate. This case series highlights the critical link between COVID-19 and intestinal ischemia, emphasizing the need for further investigation.
Area of Science:
- Gastroenterology and Infectious Diseases
- Surgical Pathology
- Critical Care Medicine
Background:
- Gastrointestinal symptoms are frequent in COVID-19 patients, but severe complications like intestinal ischemia are rare.
- This case series investigates the clinical presentation and outcomes of patients with concurrent COVID-19 and intestinal ischemia.
Observation:
- The study included 24 adult patients with COVID-19 and intestinal ischemia, with a median age of 61.5 years.
- Gastrointestinal symptoms, primarily abdominal pain, appeared a median of seven days post-COVID-19 diagnosis.
- Elevated C-Reactive Protein and D-dimer levels were observed in patients prior to surgery.
Findings:
- Bowel necrosis was present in 15 (62.5%) of the patients, leading to a high mortality rate.
- Pathologic evaluation revealed general features of intestinal necrosis, with specific cases of mucormycosis and vasculitis.
- The median hospital stay for patients with bowel necrosis was 6.5 days.
Implications:
- Intestinal ischemia in COVID-19 patients carries a significant mortality risk.
- Further research is crucial to understand the pathophysiology and management of COVID-19-associated intestinal ischemia.
More Related Videos
07:05Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital Microscopy
Published on: September 27, 2024
08:55Intestinal Stem Cell Isolation and Culture in a Porcine Model of Segmental Small Intestinal Ischemia
Published on: May 18, 2018
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...